CSF α-synuclein levels were significantly greater in Alzheimer’s disease compared with primary α-synucleinopathies such as dementia with Lewy bodies, Parkinson’s disease, and multiple system atrophy. The gene discussed is SNCA; the disease is multiple system atrophy.